Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hanwha Ocean (042660) – Correction of Decision on Acquisition of Shares or Equity Securities of Other Corporations / 2024-12-30 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Major Management Matters Related to Investment Decisions / 2025-11-24 Disclosures
  • [Disclosure] HPSP (403870) – Resolution on Calling of General Meeting of Shareholders (Extraordinary General Meeting) / 2025-09-26 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Investor Relations (IR) Holding / 2025-11-14 Defense
  • [Disclosure] Celltrion (068270) – Additional Listing (Exercise of Stock Options) / 2025-02-10 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · ADR Listing · Valuation Re-rating / 2026-03-23 RESEARCH
  • [Disclosure] KEPCO (015760 / KEP) – Provisional Consolidated Financial Results (Fair Disclosure) / 2026-05-13 Disclosures
  • [Disclosure] Wonik IPS (240810) – Change in Sales or Profit/Loss Structure by More Than 30% (15% for Large Companies) / 2025-02-26 Semiconductors

[Disclosure] Jusung Engineering (036930) – Submission of Audit Report / 2026-03-13

Posted on March 13, 2026August 3, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Jusung Engineering has submitted its FY2025 audit report, receiving an ‘Unqualified’ audit opinion from Ernst & Young Han Young for both its consolidated and separate financial statements.

📊 [Key Disclosure Contents & Summary Metrics]

  • External Auditor: Ernst & Young Han Young
  • Audit Report Receipt Date: March 13, 2026
  • Audit Opinion & Qualifications (Consolidated & Separate):
    • Audit Opinion: Unqualified
    • Material Uncertainty Related to Going Concern: Not Applicable
    • Adverse Internal Control Audit/Review Opinion: Not Applicable (Separate basis)
  • Consolidated Financial Performance:
    • Revenue: KRW 310.7B (KRW 310,692,584,812 / -24.11% YoY)
    • Operating Profit: KRW 31.3B (KRW 31,257,811,742 / -67.84% YoY)
    • Profit Before Income Tax: KRW 41.2B (KRW 41,226,195,380 / -67.66% YoY)
    • Net Profit: KRW 35.7B (KRW 35,693,416,702 / -66.58% YoY)
  • Consolidated Financial Position:
    • Total Assets: KRW 887,892,914,256 (approx. KRW 887.9B)
    • Total Liabilities: KRW 297,436,347,858 (approx. KRW 297.4B)
    • Total Equity: KRW 590,456,566,398 (approx. KRW 590.5B)
    • Capital Stock: KRW 24,124,606,000 (approx. KRW 24.1B)
  • Separate Financial Performance:
    • Revenue: KRW 310,692,584,812 (approx. KRW 310.7B)
    • Operating Profit: KRW 32,131,229,318 (approx. KRW 32.1B)
    • Net Profit: KRW 35,420,902,210 (approx. KRW 35.4B)
  • Revision Details (vs. Feb 10, 2026 Earnings Preliminary Disclosure):
    • Consolidated Net Profit: KRW 34,665,232,486 → KRW 35,693,416,702 (+KRW 1.03B)
    • Consolidated Total Liabilities: KRW 298,464,532,074 → KRW 297,436,347,858 (-KRW 1.03B)
    • Consolidated Total Equity: KRW 589,428,382,182 → KRW 590,456,566,398 (+KRW 1.03B)
  • Regulatory Financial Criteria Checklist:
    • Capital Impairment Ratio: Not Applicable (Total Equity: KRW 590.5B / Capital Stock: KRW 24.1B)
    • Loss Before Income Tax / Operating Loss: Not Applicable (Maintained Profitability)
    • Impairment Loss Ratio Exceeding 50%: No
  • Other Investment Considerations:
    • The audited financial statements remain subject to final approval at the Annual General Meeting of Shareholders.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Final Confirmed Financial Statements and Annual Report

This disclosure serves as a formal notification submitting the external auditor’s report with an ‘Unqualified’ opinion for FY2025. Note that certain metrics (such as consolidated net profit) were upwardly revised from the preliminary release on Feb 10. Verifying whether the submitted financial figures are approved without modifications at the general shareholders’ meeting is essential for confirming the company’s finalized fiscal performance and legal corporate reporting compliance. Detailed financial statements, auditor’s notes, and operating management details can be verified in the submitted ‘Annual Report’ and the subsequent ‘Results of General Shareholders’ Meeting’ disclosure.

📢 Disclaimer & Source Notice

Source: This content is structured and rewritten based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] Hanwha Systems (272210) – Execution of Single Sales or Supply Contract (Correction) / 2026-03-13
Next Post: [Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract / 2026-03-13

Related Posts

  • [Disclosure] Hanmi Semiconductor (042700) – Provisional Financial Results (Consolidated) / 2026-05-15 Semiconductors
  • [Disclosure] HPSP (403870) – Decision on Conclusion of Trust Contract for Treasury Stock Acquisition / 2024-05-14 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Compliance Program (CP) Operations Status / 2025-10-30 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Information Disclosure / 2025-11-21 Bio & Healthcare
  • [Disclosure] SK Square (402340) – Change of Listing / 2025-01-16 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Decision to Call General Shareholders’ Meeting / 2025-02-19 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Investor Relations (IR) Announcement / 2026-04-07 Semiconductors
  • [Disclosure] Jusung Engineering (036930) – Consolidated Financial Results (Provisional) / 2024-10-29 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Base Price Determination Method for Re-listing Due to Corporate Spin-off / 2024-09-26 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Acquisition of Shares and Equity Securities of Other Corporations / 2025-08-07 Disclosures
  • [Disclosure] ALTEOGEN (196170) – EYZANFY (ALT-L9, Eylea Biosimilar) Approved for Product License by MFDS / 2026-05-15 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract / 2025-04-28 Disclosures
  • [Disclosure] Hana Micron (067310) – (Correction) Decision on Corporate Split / 2025-07-25 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Results of General Meeting of Shareholders / 2025-03-19 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme